Exact Mass: 429.21268160000005
Exact Mass Matches: 429.21268160000005
Found 500 metabolites which its exact mass value is equals to given mass value 429.21268160000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
7-Benzylidenenaltrexone
C27H27NO4 (429.19399820000007)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
Melagatran
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AE - Direct thrombin inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins
Abiraterone sulfate
C24H31NO4S (429.19736860000006)
Abiraterone sulfate is a metabolite of abiraterone. Abiraterone is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) (prostate cancer not responding to androgen deprivation or treatment with antiandrogens). It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. (Wikipedia)
7-Benzylidenenaltrexone
C27H27NO4 (429.19399820000007)
Guan-fu base A
Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2]. Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2].
Hippuryl-histidyl-leucine
C21H27N5O5 (429.20120920000005)
2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid
C27H27NO4 (429.19399820000007)
Melagatran
Sarpogrelate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
8-Benzylcanadine
C27H27NO4 (429.19399820000007)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.163 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.170
2-amino-3-[[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid
C21H35NO6S (429.21849700000007)
(-)N-(12-Acetoxy)jasmonoyl-phenylalaninmethylester
acehytisine
Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2]. Guanfu base A is an antiarrhythmic alkaloid isolated from Aconitum coreanum and is a potent noncompetitive CYP2D6 inhibitor, with a Ki of 1.20 μM in human liver microsomes (HLMs) and a Ki of 0.37 μM for the human recombinant form (rCYP2D6). Guanfu base A is also a potent competitive inhibitor of CYP2D in monkey (Ki of 0.38 μM) and dog (Ki of 2.4 μM) microsomes[1]. Guanfu base A also inhibits HERG channel current[2].
C21H35NO6S_Cysteine, S-[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxooxacyclotetradeca-6,9-dien-4-yl]
C21H35NO6S (429.21849700000007)
2-amino-3-[[(6E,9E)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid_major
C21H35NO6S (429.21849700000007)
Ala Asp Lys Pro
Ala Asp Pro Lys
Ala Asp Pro Gln
C17H27N5O8 (429.18595419999997)
Ala Asp Gln Pro
C17H27N5O8 (429.18595419999997)
Ala Glu Asn Pro
C17H27N5O8 (429.18595419999997)
Ala Glu Pro Asn
C17H27N5O8 (429.18595419999997)
Ala Gly Pro Trp
C21H27N5O5 (429.20120920000005)
Ala Gly Trp Pro
C21H27N5O5 (429.20120920000005)
Ala Lys Asp Pro
Ala Lys Pro Asp
Ala Asn Glu Pro
C17H27N5O8 (429.18595419999997)
Ala Asn Pro Glu
C17H27N5O8 (429.18595419999997)
Ala Pro Asp Lys
Ala Pro Asp Gln
C17H27N5O8 (429.18595419999997)
Ala Pro Glu Asn
C17H27N5O8 (429.18595419999997)
Ala Pro Gly Trp
C21H27N5O5 (429.20120920000005)
Ala Pro Lys Asp
Ala Pro Asn Glu
C17H27N5O8 (429.18595419999997)
Ala Pro Gln Asp
C17H27N5O8 (429.18595419999997)
Ala Pro Arg Ser
Ala Pro Ser Arg
Ala Pro Trp Gly
C21H27N5O5 (429.20120920000005)
Ala Gln Asp Pro
C17H27N5O8 (429.18595419999997)
Ala Gln Pro Asp
C17H27N5O8 (429.18595419999997)
Ala Arg Pro Ser
Ala Arg Ser Pro
Ala Ser Pro Arg
Ala Ser Arg Pro
Ala Trp Gly Pro
C21H27N5O5 (429.20120920000005)
Ala Trp Pro Gly
C21H27N5O5 (429.20120920000005)
Asp Ala Lys Pro
Asp Ala Pro Lys
Asp Ala Pro Gln
C17H27N5O8 (429.18595419999997)
Asp Ala Gln Pro
C17H27N5O8 (429.18595419999997)
Asp Lys Ala Pro
Asp Lys Pro Ala
Asp Pro Ala Lys
Asp Pro Ala Gln
C17H27N5O8 (429.18595419999997)
Asp Pro Lys Ala
Asp Pro Gln Ala
C17H27N5O8 (429.18595419999997)
Asp Gln Ala Pro
C17H27N5O8 (429.18595419999997)
Asp Gln Pro Ala
C17H27N5O8 (429.18595419999997)
Glu Ala Asn Pro
C17H27N5O8 (429.18595419999997)
Glu Ala Pro Asn
C17H27N5O8 (429.18595419999997)
Glu Gly Lys Pro
Glu Gly Pro Lys
Glu Gly Pro Gln
C17H27N5O8 (429.18595419999997)
Glu Gly Gln Pro
C17H27N5O8 (429.18595419999997)
Glu Lys Gly Pro
Glu Lys Pro Gly
Glu Asn Ala Pro
C17H27N5O8 (429.18595419999997)
Glu Asn Pro Ala
C17H27N5O8 (429.18595419999997)
Glu Pro Ala Asn
C17H27N5O8 (429.18595419999997)
Glu Pro Gly Lys
Glu Pro Gly Gln
C17H27N5O8 (429.18595419999997)
Glu Pro Lys Gly
Glu Pro Asn Ala
C17H27N5O8 (429.18595419999997)
Glu Pro Gln Gly
C17H27N5O8 (429.18595419999997)
Glu Gln Gly Pro
C17H27N5O8 (429.18595419999997)
Glu Gln Pro Gly
C17H27N5O8 (429.18595419999997)
Gly Ala Pro Trp
C21H27N5O5 (429.20120920000005)
Gly Ala Trp Pro
C21H27N5O5 (429.20120920000005)
Gly Glu Lys Pro
Gly Glu Pro Lys
Gly Glu Pro Gln
C17H27N5O8 (429.18595419999997)
Gly Glu Gln Pro
C17H27N5O8 (429.18595419999997)
Gly Lys Glu Pro
Gly Lys Pro Glu
Gly Pro Ala Trp
C21H27N5O5 (429.20120920000005)
Gly Pro Glu Lys
Gly Pro Glu Gln
C17H27N5O8 (429.18595419999997)
Gly Pro Lys Glu
Gly Pro Gln Glu
C17H27N5O8 (429.18595419999997)
Gly Pro Arg Thr
Gly Pro Thr Arg
Gly Pro Trp Ala
C21H27N5O5 (429.20120920000005)
Gly Gln Glu Pro
C17H27N5O8 (429.18595419999997)
Gly Gln Pro Glu
C17H27N5O8 (429.18595419999997)
Gly Arg Pro Thr
Gly Arg Thr Pro
Gly Thr Pro Arg
Gly Thr Arg Pro
Gly Trp Ala Pro
C21H27N5O5 (429.20120920000005)
Gly Trp Pro Ala
C21H27N5O5 (429.20120920000005)
Ile Asn Pro Ser
Ile Asn Ser Pro
Ile Pro Asn Ser
Ile Pro Ser Asn
Ile Ser Asn Pro
Ile Ser Pro Asn
Lys Ala Asp Pro
Lys Ala Pro Asp
Lys Asp Ala Pro
Lys Asp Pro Ala
Lys Glu Gly Pro
Lys Glu Pro Gly
Lys Gly Glu Pro
Lys Gly Pro Glu
Lys Pro Ala Asp
Lys Pro Asp Ala
Lys Pro Glu Gly
Lys Pro Gly Glu
Leu Asn Pro Ser
Leu Asn Ser Pro
Leu Pro Asn Ser
Leu Pro Ser Asn
Leu Ser Asn Pro
Leu Ser Pro Asn
Asn Ala Glu Pro
C17H27N5O8 (429.18595419999997)
Asn Ala Pro Glu
C17H27N5O8 (429.18595419999997)
Asn Glu Ala Pro
C17H27N5O8 (429.18595419999997)
Asn Glu Pro Ala
C17H27N5O8 (429.18595419999997)
Asn Ile Pro Ser
Asn Ile Ser Pro
Asn Leu Pro Ser
Asn Leu Ser Pro
Asn Pro Ala Glu
C17H27N5O8 (429.18595419999997)
Asn Pro Glu Ala
C17H27N5O8 (429.18595419999997)
Asn Pro Ile Ser
Asn Pro Leu Ser
Asn Pro Ser Ile
Asn Pro Ser Leu
Asn Pro Thr Val
Asn Pro Val Thr
Asn Ser Ile Pro
Asn Ser Leu Pro
Asn Ser Pro Ile
Asn Ser Pro Leu
Asn Thr Pro Val
Asn Thr Val Pro
Asn Val Pro Thr
Asn Val Thr Pro
Pro Ala Asp Lys
Pro Ala Asp Gln
C17H27N5O8 (429.18595419999997)
Pro Ala Glu Asn
C17H27N5O8 (429.18595419999997)
Pro Ala Gly Trp
C21H27N5O5 (429.20120920000005)
Pro Ala Lys Asp
Pro Ala Asn Glu
C17H27N5O8 (429.18595419999997)
Pro Ala Gln Asp
C17H27N5O8 (429.18595419999997)
Pro Ala Arg Ser
Pro Ala Ser Arg
Pro Ala Trp Gly
C21H27N5O5 (429.20120920000005)
Pro Asp Ala Lys
Pro Asp Ala Gln
C17H27N5O8 (429.18595419999997)
Pro Asp Lys Ala
Pro Asp Gln Ala
C17H27N5O8 (429.18595419999997)
Pro Glu Ala Asn
C17H27N5O8 (429.18595419999997)
Pro Glu Gly Lys
Pro Glu Gly Gln
C17H27N5O8 (429.18595419999997)
Pro Glu Lys Gly
Pro Glu Asn Ala
C17H27N5O8 (429.18595419999997)
Pro Glu Gln Gly
C17H27N5O8 (429.18595419999997)
Pro Gly Ala Trp
C21H27N5O5 (429.20120920000005)
Pro Gly Glu Lys
Pro Gly Glu Gln
C17H27N5O8 (429.18595419999997)
Pro Gly Lys Glu
Pro Gly Gln Glu
C17H27N5O8 (429.18595419999997)
Pro Gly Arg Thr
Pro Gly Thr Arg
Pro Gly Trp Ala
C21H27N5O5 (429.20120920000005)
Pro Ile Asn Ser
Pro Ile Ser Asn
Pro Lys Ala Asp
Pro Lys Asp Ala
Pro Lys Glu Gly
Pro Lys Gly Glu
Pro Leu Asn Ser
Pro Leu Ser Asn
Pro Asn Ala Glu
C17H27N5O8 (429.18595419999997)
Pro Asn Glu Ala
C17H27N5O8 (429.18595419999997)
Pro Asn Ile Ser
Pro Asn Leu Ser
Pro Asn Ser Ile
Pro Asn Ser Leu
Pro Asn Thr Val
Pro Asn Val Thr
Pro Gln Ala Asp
C17H27N5O8 (429.18595419999997)
Pro Gln Asp Ala
C17H27N5O8 (429.18595419999997)
Pro Gln Glu Gly
C17H27N5O8 (429.18595419999997)
Pro Gln Gly Glu
C17H27N5O8 (429.18595419999997)
Pro Gln Ser Val
Pro Gln Val Ser
Pro Arg Ala Ser
Pro Arg Gly Thr
Pro Arg Ser Ala
Pro Arg Thr Gly
Pro Ser Ala Arg
Pro Ser Ile Asn
Pro Ser Leu Asn
Pro Ser Asn Ile
Pro Ser Asn Leu
Pro Ser Gln Val
Pro Ser Arg Ala
Pro Ser Val Gln
Pro Thr Gly Arg
Pro Thr Asn Val
Pro Thr Arg Gly
Pro Thr Val Asn
Pro Val Asn Thr
Pro Val Gln Ser
Pro Val Ser Gln
Pro Val Thr Asn
Pro Trp Ala Gly
C21H27N5O5 (429.20120920000005)
Pro Trp Gly Ala
C21H27N5O5 (429.20120920000005)
Gln Ala Asp Pro
C17H27N5O8 (429.18595419999997)
Gln Ala Pro Asp
C17H27N5O8 (429.18595419999997)
Gln Asp Ala Pro
C17H27N5O8 (429.18595419999997)
Gln Asp Pro Ala
C17H27N5O8 (429.18595419999997)
Gln Glu Gly Pro
C17H27N5O8 (429.18595419999997)
Gln Glu Pro Gly
C17H27N5O8 (429.18595419999997)
Gln Pro Ser Val
Gln Pro Val Ser
Gln Ser Pro Val
Gln Ser Val Pro
Gln Val Pro Ser
Gln Val Ser Pro
Arg Ala Pro Ser
Arg Ala Ser Pro
Arg Gly Pro Thr
Arg Gly Thr Pro
Arg Pro Ala Ser
Arg Pro Gly Thr
Arg Pro Ser Ala
Arg Pro Thr Gly
Arg Ser Ala Pro
Arg Ser Pro Ala
Arg Thr Gly Pro
Arg Thr Pro Gly
Ser Ala Pro Arg
Ser Ala Arg Pro
Ser Ile Asn Pro
Ser Ile Pro Asn
Ser Leu Asn Pro
Ser Leu Pro Asn
Ser Asn Ile Pro
Ser Asn Leu Pro
Ser Asn Pro Ile
Ser Asn Pro Leu
Ser Pro Ala Arg
Ser Pro Ile Asn
Ser Pro Leu Asn
Ser Pro Asn Ile
Ser Pro Asn Leu
Ser Pro Gln Val
Ser Pro Arg Ala
Ser Pro Val Gln
Ser Gln Pro Val
Ser Gln Val Pro
Ser Arg Ala Pro
Ser Arg Pro Ala
Ser Val Pro Gln
Ser Val Gln Pro
Thr Gly Pro Arg
Thr Gly Arg Pro
Thr Asn Pro Val
Thr Asn Val Pro
Thr Pro Gly Arg
Thr Pro Asn Val
Thr Pro Arg Gly
Thr Pro Val Asn
Thr Arg Gly Pro
Thr Arg Pro Gly
Thr Val Asn Pro
Thr Val Pro Asn
Val Asn Pro Thr
Val Asn Thr Pro
Val Pro Asn Thr
Val Pro Gln Ser
Val Pro Ser Gln
Val Pro Thr Asn
Val Gln Pro Ser
Val Gln Ser Pro
Val Ser Pro Gln
Val Ser Gln Pro
Val Thr Asn Pro
Val Thr Pro Asn
Trp Ala Gly Pro
C21H27N5O5 (429.20120920000005)
Trp Ala Pro Gly
C21H27N5O5 (429.20120920000005)
Trp Gly Ala Pro
C21H27N5O5 (429.20120920000005)
Trp Gly Pro Ala
C21H27N5O5 (429.20120920000005)
Trp Pro Ala Gly
C21H27N5O5 (429.20120920000005)
Trp Pro Gly Ala
C21H27N5O5 (429.20120920000005)
2-hydroxyethyl 2-methylprop-2-enoate,2-methylidenehexanoate,methyl 2-methylprop-2-enoate,prop-2-enoic acid
C21H33O9- (429.21244680000007)
(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-3-(4-ISOPROPYL-PHENYL)-PROPIONIC ACID
C27H27NO4 (429.19399820000007)
3-(Biphenyl-4-yl)-5-(4-tert-butylphenyl)-4-phenyl-4H-1,2,4-triazole
4-[BUTYL([2-(1H-TETRAZOL-5-YL)[1,1-BIPHENYL]-4-YL]METHYL)AMINO]-5-PYRIMIDINECARBOXYLIC ACID
Thiourea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-(3-methylphenyl)-N-(3-pyridinylmethyl)- (9CI)
C25H27N5S (429.19870620000006)
(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-[(1S)-1-cyclohexylethyl]pyrrolidine-1-carboxamide
ON-123300
Narazaciclib (ON123300), a strong and brain-penetrant[1] multi-kinase inhibitor, inhibits CDK4 (IC50=3.9 nM), Ark5 (IC50=5 nM), PDGFRβ (IC50=26 nM), FGFR1 (IC50=26 nM), RET (IC50=9.2 nM), and FYN (IC50=11 nM). Single agent Narazaciclib causes a dose-dependent suppression of phosphorylation of Akt as well as activation of Erk in brain tumors[2]. Narazaciclib inhibits CDK6 with an IC50 of 9.82 nM[3].
3-{2-[4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
C23H28FN3O4 (429.20637400000004)
Evobrutinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent
7-[2(S)-[3(R)-Hydroxy-4-[3-(trifluoromethyl)phenyl]butyl]-5-oxopyrrolidin-1-yl]heptanoic acid
C22H30F3NO4 (429.21268160000005)
17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlori de dihydrate
C21H32ClNO6 (429.19180420000004)
6-[2-Oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-(phenylmethyl)-7-triazolo[4,5-d]pyrimidinone
Sarpogrelate
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
(6E)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
C27H27NO4 (429.19399820000007)
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)-
C27H27NO4 (429.19399820000007)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists
2-Amino-6-ethyl-4-(4-methoxyphenyl)-8-[(4-methoxyphenyl)methyl]-4,5-dihydropyrano[3,2-c]pyridine-3-carbonitrile
C26H27N3O3 (429.20523120000007)
1-acetyl-6-[2-(4-ethyl-1-piperazinyl)-2-oxoethoxy]-4-spiro[3,4-dihydro-2H-1-benzopyran-2,4-piperidine]one
1-[2-[[4,6-Bis(4-morpholinyl)-1,3,5-triazin-2-yl]oxy]ethyl]-3-phenylurea
C20H27N7O4 (429.21244220000005)
N-[1-methyl-2-[2-(4-phenyl-1-piperazinyl)ethyl]-5-benzimidazolyl]-2-furancarboxamide
4-[[[2-(1-Azepanyl)ethyl-(2-furanylmethyl)amino]-sulfanylidenemethyl]amino]benzoic acid ethyl ester
C23H31N3O3S (429.20860160000007)
2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide
C23H31N3O3S (429.20860160000007)
1-methyl-4-[2-oxo-2-(N-(phenylmethyl)anilino)ethyl]-5-pyrrolo[3,2-b]pyrrolecarboxylic acid propan-2-yl ester
C26H27N3O3 (429.20523120000007)
(12S,13R,16R,8S)-13-methoxy-6,8,10-trimethyl-5,9-dioxo-13,14,15,16-tetrahydro-12H-3-oxa-6,10-diaza-1(2,6)-pyrana-4(1,2)-benzenacyclododecaphane-44-carbonitrile
(12S,13R,16R,8S)-13-methoxy-6,8,10-trimethyl-5,9-dioxo-13,14,15,16-tetrahydro-12H-3-oxa-6,10-diaza-1(2,6)-pyrana-4(1,2)-benzenacyclododecaphane-46-carbonitrile
(4As,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
C27H27NO4 (429.19399820000007)
(1S,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,9S,10S,11S)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H25F2N3O3 (429.18638839999994)
(1R,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,9R,10R,11R)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C20H26F3N3O4 (429.1875312000001)
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
(1R,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1S,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,13S,18R,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13R,18R,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13R,18S,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13S,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1S,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1S,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(3-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-(4-pyrimidinylmethyl)acetamide
C21H27N5O5 (429.20120920000005)
(1R,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5,7,9-triene-6-carbonitrile
(1R,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1S,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5,7,9-triene-6-carbonitrile
(1R,14R,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14S,18S,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18S,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14R,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18R,19R)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1S,14S,18R,19S)-19-methoxy-12,14,16-trimethyl-11,15-dioxo-4,22-dioxa-12,16-diazatricyclo[16.3.1.05,10]docosa-5(10),6,8-triene-8-carbonitrile
(1R,13R,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13S,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13S,18S,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13S,18R,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1R,13R,18S,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4(9),5,7-triene-7-carbonitrile
(1S,13S,18S,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13R,18R,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13S,18R,21R)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1R,13S,18R,21S)-21-methoxy-11,13,15-trimethyl-10,14-dioxo-3,22-dioxa-11,15-diazatricyclo[16.3.1.04,9]docosa-4,6,8-triene-5-carbonitrile
(1S,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4,6,8-triene-5-carbonitrile
(1R,19R,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1R,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19S,22R)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19R,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19S,22S)-22-methoxy-11,16-dimethyl-10,15-dioxo-3,23-dioxa-11,16-diazatricyclo[17.3.1.04,9]tricosa-4(9),5,7-triene-7-carbonitrile
(1S,19S,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1R,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,19S,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1R,19R,20R)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1R,19R,20S)-20-methoxy-12,17-dimethyl-11,16-dioxo-4,23-dioxa-12,17-diazatricyclo[17.3.1.05,10]tricosa-5(10),6,8-triene-8-carbonitrile
(1S,9R,10R,11R)-N-cyclobutyl-12-[(2,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C23H25F2N3O3 (429.18638839999994)
(1R,9S,10S,11S)-10-(hydroxymethyl)-12-(oxan-4-ylmethyl)-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C20H26F3N3O4 (429.1875312000001)
3-[4-[(1S,5R)-3-[(2-fluorophenyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
3-[4-(2-Benzyl-5-tert-butylpyrazole-3-carbonyl)piperazin-1-yl]pyrazine-2-carbonitrile
(3S,12Z)-14,14,21,21-tetramethyl-22-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.018,23]hexacosa-1(15),8,12,17(26),18(23),19,24-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)
(3S,12Z)-14,14,21,21-tetramethyl-20-oxa-5,11,16-triazahexacyclo[13.11.0.03,11.05,9.017,26.019,24]hexacosa-1(15),8,12,17(26),18,22,24-heptaene-4,10-dione
C26H27N3O3 (429.20523120000007)
2-amino-3-[[(6Z,9Z)-5-hydroxy-8-methoxy-5,9,13,14-tetramethyl-2-oxo-1-oxacyclotetradeca-6,9-dien-4-yl]sulfanyl]propanoic acid
C21H35NO6S (429.21849700000007)
[(8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulate
C24H31NO4S (429.19736860000006)
asnovolin I(1-)
A monocarboxylic acid anion that is the conjugate base of asnovolin I resulting from the deprotonation of the carboxy group. Major microspecies at pH 7.3.
4F 4PP (oxalate)
C24H28FNO5 (429.19514100000004)
4F 4PP (oxalate) is a selective 5-HT2A antagonist with almost as high affinity (Ki= 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki= 620 nM)[1][2][3][4].
BML-280
BML-280 (VU0285655-1) is a potent and selective phospholipase D2 (PLD2) inhibitor. BML-280 has the ability to prevent caspase-3 cleavage and reduction in cell viability induced by high glucose. BML-280 can be used for rheumatoid arthritis research[1][2].